Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/7/18 → 8/31/23 |
Funding
- Rho, Inc (Prot #MRT5005-101 // Prot #MRT5005-101)
- Translate Bio, Inc. (Prot #MRT5005-101 // Prot #MRT5005-101)
Prot #MRT5005-101: A Phase 1/2, Randomized, Double-Blind, Placebo-Controlled, Combined Single and Multiple Ascending Dose Study Evaluating the Safety, Tolerability, and Biological Activity of MRT5005 (CO-hCFTR mRNA/ICE LNP) Administered by Nebulization to
- Jain, Manu (PD/PI)
Project: Research project